Company Logo

Companion Animal Ear Infection Treatment Market Overview Highlighting Major Drivers, Trends Report 2028

New Business Consulting

Updated on Oct 11, 2023

View more like this | Visit United States Minor Outlying Islands, UN | Contact Market Research Reports
Image for Companion Animal Ear Infection Treatment Market Overview Highlighting Major Drivers, Trends Report 2028 with ID of: 5368993

Companion Animal Ear Infection Treatment Industry Overview

The global companion animal ear infection treatment market size was valued at USD 531.2 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2021 to 2028.

 

Increased prevalence of otitis externa in pets is propelling the market growth. According to Dechra Pharmaceuticals, otitis or ear infection is the final diagnosis in 2% of all feline and 5% of all canine consultations currently. During the COVID-19 pandemic, limited operation of veterinary clinics due to stringent lockdown norms consequently resulted in a decline in veterinary visits, thus impacting the market. However, the market has shown a V-shaped recovery during the 3rd quarter of 2020 due to the resumption of pet clinics and ease of norms. According to IDEXX, U.S. clinic visits increased by 6% in Q4 2020 from the last quarter, which is expected to boost the market growth over the forecast period.

 

Gather more insights about the market drivers, restrains and growth of the Global Companion Animal Ear Infection Treatment Market

 

Though COVID-19 restricted outdoor visits, otitis remained in the list of top 10 pet insurance claims in 2020 according to Trupanion, a pet insurance provider based in the U.S. The company received around 6,000 claims for otitis between March 1 to May 31, 2020. In April 2019, the North American veterinary dermatology forum reported better resolution of clinical signs of otitis in referral dermatology practice settings as compared to primary care.

 

Growth in the pet population is expected to increase the demand for veterinary healthcare services and boost the overall expenditure on pets. According to the American Pet Products Association report, overall spending in the U.S. pet industry was USD 103.6 billion in 2020 and is expected to reach USD 110 billion by 2021. Veterinary care spending increased by 560% between 1994 and 2020.

 

Industry players are also continuously trying to strengthen their market position through various strategies, such as regional expansion, new product launches, partnership & collaboration, etc. In February 2020, Bayer (Elanco) launched Neptra ear solution in the U.K. market to increase its geographic footprint. In December 2019, Vetoquinol and Klox Technologies had entered into a global licensing agreement, excluding China.

 

Browse through Grand View Research's Animal Health Industry Research Reports.

  • Animal Biotechnology Market: The global animal biotechnology market size was valued at USD 22.66 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2022 to 2030.
  • Veterinary Lasers Market: The global veterinary lasers market size was valued at USD 83.9 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.7% from 2022 to 2030.

 

Companion Animal Ear Infection Treatment Market Segmentation

Grand View Research has segmented the global companion animal ear infection treatment market on the basis of product, disease type, mode of administration, animal type, and region:

Companion Animal Ear Infection Treatment Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Anti-bacterial
  • Anti-fungal
  • Corticosteroids
  • Others

Companion Animal Ear Infection Treatment Disease Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Otitis Externa
  • Otitis Media
  • Otitis Interna

Companion Animal Ear Infection Treatment Mode of Administration Outlook (Revenue, USD Million, 2016 - 2028)

  • Topical
  • Oral
  • Otic

Companion Animal Ear Infection Treatment Animal Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Dogs
  • Cats
  • Others

Companion Animal Ear Infection Treatment Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Market Share Insights

  • August 2020: Elanco also increased its market penetration after acquiring Bayer.
  • April 2020: Virbac launched Easoticotic suspension for canine otitis externa. 
  • June 2019: Virbac launched Cortavance, a topical corticosteroid spray in India across 4 metro cities. 

 

Key Companies profiled:

Some of the prominent players in the global companion animal ear infection treatment market include:

  • Zoetis
  • Elanco
  • Dechra Pharmaceuticals
  • Merck & Co., Inc.
  • Vetoquinol
  • Penn Veterinary Supply, Inc.
  • Virbac S.A.
  • Ceva Santé Animale
  • Vedco, Inc.

 

Order a free sample PDF of the Companion Animal Ear Infection Treatment Market Intelligence Study, published by Grand View Research.

 

goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.